tradingkey.logo
tradingkey.logo
Search

US pharma stocks mostly firm after Trump tariffs

ReutersSep 26, 2025 11:48 AM
facebooktwitterlinkedin
View all comments0

Shares of major U.S. drugmakers were mostly stable or marginally up after President Donald Trump announced 100% tariffs on branded drugs imported by firms that are not building plants in U.S.

Shares of Abbvie ABBV.N, Merck MRK.N and Eli Lilly LLY.N were up 1% premarket

Shares of Amgen AMGN.O, Pfizer PFE.N, Johnson & Johnson BIIB.O and Bristol Myers Squibb BMY.N rose marginally

Most of these companies had been boosting their U.S. manufacturing while the Trump administration weighed hefty tariffs on pharmaceutical imports into the country

Up to last close, LLY down 7.4%, BMY down 23.3% and PFE down 11% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI